BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Maryam Ranjpour, Saima Wajid, Swatantra K. Jain. Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer ProgressionAnti-Cancer Agents in Medicinal Chemistry 2019; 19(2): 236 doi: 10.2174/1871520618666181015142810
2
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_34-1
3
Moamena S. El-Hamouly, Ayman A. Azzam, Samar E. Ghanem, Fathia I. EL-Bassal, Nashwa Shebl, Amira M. F. Shehata. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinomaMolecular Biology Reports 2019; 46(6): 5759 doi: 10.1007/s11033-019-05009-w
4
Chi-Ting Horng, Chien-Wei Huang, Mon-Yuan Yang, Tzu-Hsin Chen, Yun-Ching Chang, Chau-Jong Wang. Nelumbo nuciferaleaf extract treatment attenuated preneoplastic lesions and oxidative stress in the livers of diethylnitrosamine-treated ratsEnvironmental Toxicology 2017; 32(11): 2327 doi: 10.1002/tox.22434
5
Fei Huang, Junying Chen, Ruilong Lan, Zeng Wang, Ruiqing Chen, Jingan Lin, Lengxi Fu. Hypoxia induced δ-Catenin to enhance mice hepatocellular carcinoma progression via Wnt signalingExperimental Cell Research 2019; 374(1): 94 doi: 10.1016/j.yexcr.2018.11.011
6
Yuxin Chen, Yanping Wu, Xiao Zhang, Hong Zeng, Ya Liu, Qi Wu, Yan Chen, GuoQing Zhu, Qiuhui Pan, Lei Jin, Lin Guo, Fenyong Sun. Angiopoietin-2 (Ang-2) is a useful serum tumor marker for liver cancer in the Chinese populationClinica Chimica Acta 2018; 478: 18 doi: 10.1016/j.cca.2017.12.017
7
James C. R. Wadkin, Daniel A. Patten, Sivesh K. Kamarajah, Emma L. Shepherd, Vera Novitskaya, Fedor Berditchevski, David H. Adams, Chris J. Weston, Shishir Shetty. CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinomaAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 313(2): G138 doi: 10.1152/ajpgi.00411.2016
8
Rui Caetano Oliveira, Ricardo Martins, Ana Margarida Abrantes, Ângela Jesus, Paulo Teixeira, Carolina Canhoto, Pedro Guerreiro, Beatriz Costa, Mário Rui Silva, José Guilherme Tralhão, Maria Augusta Cipriano. Morphophenotypic Classification of Hepatocellular Carcinoma: the Biliary/Stem Cell Subgroup and Worst Outcome—Implications on Patient SelectionJournal of Gastrointestinal Surgery 2020;  doi: 10.1007/s11605-020-04611-9
9
Feng Zhou, Han-Zhang Huang, Meng-Tao Zhou, Shao-Liang Han. Surgical Treatment and Chemotherapy of Adult Primary Liver Sarcoma: Experiences from a Single Hospital in ChinaDigestive Surgery 2019; 36(1): 46 doi: 10.1159/000486454
10
Qian-Hui Xu, Pei-Wen Zhu, Biao Li, Wen-Qing Shi, Qi Lin, You-Lan Min, Qian-Min Ge, Qing Yuan, Yi Shao. Carbohydrate antigen-125, calcium, and hemoglobin as predictive clinical indicator for ocular metastasis in male liver cancer patientsBioscience Reports 2020; 40(2) doi: 10.1042/BSR20194405
11
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis BClinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
12
Susanne Smolka, Julius Chapiro, Wilfred Manzano, John Treilhard, Eric Reiner, Yanhong Deng, Yan Zhao, Bernd Hamm, James S. Duncan, Bernhard Gebauer, MingDe Lin, Jean-François Geschwind. The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinomaClinical Imaging 2017; 46: 1 doi: 10.1016/j.clinimag.2017.05.007
13
Jin U. Kim, I. Jane Cox, Simon D. Taylor-Robinson. The Quest for Relevant Hepatocellular Carcinoma BiomarkersCellular and Molecular Gastroenterology and Hepatology 2017; 4(2): 283 doi: 10.1016/j.jcmgh.2017.06.003
14
S Shalini, A Nikolic, C H Wilson, J Puccini, N Sladojevic, J Finnie, L Dorstyn, S Kumar. Caspase-2 deficiency accelerates chemically induced liver cancer in miceCell Death & Differentiation 2016; 23(10): 1727 doi: 10.1038/cdd.2016.81
15
Min Cong, Xiaojuan Ou, Jian Huang, Jiang Long, Tong Li, Xueen Liu, Yanhong Wang, Xiaoning Wu, Jialing Zhou, Yameng Sun, Qinghua Shang, Guofeng Chen, Hui Ma, Wen Xie, Hongxin Piao, Yongping Yang, Zhiliang Gao, Xiaoyuan Xu, Zongnan Tan, Chitty Chen, Na Zeng, Shanshan Wu, Yuanyuan Kong, Tianhui Liu, Ping Wang, Hong You, Jidong Jia, Hui Zhuang. A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B VirusOMICS: A Journal of Integrative Biology 2020; 24(7): 415 doi: 10.1089/omi.2020.0055
16
Bothina Madkour, Alaa Gad, Mona S. Hamdy, Nariman Zahran, Mohamed Aboul-Ezz. Interleukin-6-572 promoter gene polymorphism and its association with chronic hepatitis C-induced hepatocellular carcinoma: an Egyptian studyComparative Clinical Pathology 2018; 27(1): 161 doi: 10.1007/s00580-017-2571-7
17
Mustafa A. Barbhuiya, Adam C. Mirando, Brian W. Simons, Ghali Lemtiri-Chlieh, Jordan J. Green, Aleksander S. Popel, Niranjan B. Pandey, Phuoc T. Tran. Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinomaOncotarget 2017; 8(60): 101520 doi: 10.18632/oncotarget.21148
18
Yunyang Chen, Shaoming Li, Wei Li, Rongbing Yang, Xianguang Zhang, Yong Ye, Jiexiong Yu, Lin Ye, Wangrong Tang. Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43572-1
19
Liangliang Shi, Li Ba, Ying Xiong, Gang Peng. A hybridization chain reaction based assay for fluorometric determination of exosomes using magnetic nanoparticles and both aptamers and antibody as recognition elementsMicrochimica Acta 2019; 186(12) doi: 10.1007/s00604-019-3823-9
20
Carina Hage, Sabine Hoves, Mailin Ashoff, Veronika Schandl, Stefan Hört, Natascha Rieder, Christian Heichinger, Marco Berrera, Carola H. Ries, Fabian Kiessling, Thomas Pöschinger, Roger Chammas. Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapyPLOS ONE 2019; 14(7): e0219517 doi: 10.1371/journal.pone.0219517
21
Qingjia Chi, Xinge Geng, Kang Xu, Chunli Wang, Han Zhao. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysisBioscience Reports 2020; 40(6) doi: 10.1042/BSR20200124
22
Mohamed M. Omran, Khaled Farid, Mona A. Omar, Tarek M. Emran, Fathy M. El-Taweel, Ashraf A. Tabll. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinomaAnnals of Hepatology 2020; 19(2): 179 doi: 10.1016/j.aohep.2019.09.002
23
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 837 doi: 10.1007/978-94-007-7675-3_34
24
Inga Hochnadel, Uta Kossatz-Boehlert, Nils Jedicke, Henrike Lenzen, Michael P. Manns, Tetyana Yevsa. Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancersHuman Vaccines & Immunotherapeutics 2017; 13(12): 2931 doi: 10.1080/21645515.2017.1359362
25
Adi Zheng, Nadja Chevalier, Margot Calderoni, Gilles Dubuis, Olivier Dormond, Panos G. Ziros, Gerasimos P. Sykiotis, Christian Widmann. CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinomaOncotarget 2019; 10(66): 7058 doi: 10.18632/oncotarget.27361
26
Shanshan Jiang, Qian Wang, Meiqing Feng, Jiyang Li, Zhongbin Guan, Duopeng An, Mengxue Dong, Yuzhe Peng, Kudelaidi Kuerban, Li Ye. C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cellsApplied Microbiology and Biotechnology 2017; 101(4): 1535 doi: 10.1007/s00253-016-7930-9
27
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosisWorld Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
28
Pro Kit Cheung, Man Hin Ma, Hing Fung Tse, Ka Fai Yeung, Hin Fung Tsang, Man Kee Maggie Chu, Chau Ming Kan, William Chi Shing Cho, Lawrence Bo Wah Ng, Lawrence Wing Chi Chan, Sze Chuen Cesar Wong. The applications of metabolomics in the molecular diagnostics of cancerExpert Review of Molecular Diagnostics 2019; 19(9): 785 doi: 10.1080/14737159.2019.1656530
29
Houyong Long, Xingjun Guo, Shen Qiao, Qingxing Huang. Tumor LXR Expression is a Prognostic Marker for Patients with Hepatocellular CarcinomaPathology & Oncology Research 2018; 24(2): 339 doi: 10.1007/s12253-017-0249-8
30
Muhammad Afzal, Muhammad Imran, Muhammad Akhtar, Muhammad Iqbal. Increased Renal Parenchymal Retention of 99mTc-MDP (Hot Kidneys) in Two Patient of Hepatocellular cancer: One with and other without Osseous MetastasesEuropean Journal of Medical Case Reports 2017; : 74 doi: 10.24911/ejmcr/1/19
31
Keungmo Yang, Pil S. Sung, Young K. You, Dong G. Kim, Jung S. Oh, Ho J. Chun, Jeong W. Jang, Si H. Bae, Jong Y. Choi, Seung K. Yoon. Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of responseHPB 2019; 21(12): 1718 doi: 10.1016/j.hpb.2019.04.017